Navigation Links
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
Date:3/28/2010

Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

Sheffield, MA (Vocus) March 28, 2010 -- Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

The state agency approved the new product for exterior and interior applications after the material met rigorous performance standards for human impact, flammability and weathering life. These standards often serve as a benchmark for public facilities in other states as well.

According to the manufacturer, Makrolon MAK 15 is the result of a five-year R&D program with its parent-company Bayer Material Science, LLC. In addition to its inherent break-resistance, the new material delivers up to twice the abrasion resistance and weathering life due to UV exposure over prior polycarbonate sheet materials. As a result, provides longer life and reduced maintenance for external glazing and for interior partitions, windows and doors.

Based on performance improvements made possible with its new technology, Sheffield Plastics also backs Makrolon MAK 15 with an unprecedented 15 year warranty on weathering life, yellowing, abrasion resistance and breakage.

The new product is available through the manufacturer’s national network of distributors. Administrators and facilities managers can find complete information on the product at www.sheffieldplastics.com or by calling the company at 1-877- 413-7957.

Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 15,100 employees at 30 sites around the world and 2008 sales of 9.7 billion euros. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries.

Contact:
Cindy Kahlstrom
Phone: 413-528-7812
E-mail: cindy(dot)kahlstrom(at)bayerbms(dot)com

For more information about Bayer MaterialScience, call 1-800-628-5084, email us at info(at)sheffieldplastics(dot)com or visit www.sheffieldplastics.com

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

# # #

Read the full story at http://www.prweb.com/releases/2010/03/prweb3790624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network
2. MHPA Statement on Health Reform Legislation
3. Prostate Cancer Treatment Database Hits Milestone of 12,500
4. BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now
5. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
6. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
7. Male Infertility Significantly Increases Risk of Prostate Cancer
8. Texas is 39th State to Defend Health Care Choice
9. Statement of US Secretary of Labor Hilda L. Solis on passage of health care reform by US House of Representatives
10. GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
11. Infertility Raises Risk of More Aggressive Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
(Date:4/26/2017)... ... April 26, 2017 , ... ... Excellence specializes in pelvic conditions and has helped many women become pregnant upon ... a combination of office-based and simple outpatient evaluations. We can provide the ...
(Date:4/26/2017)... ... 26, 2017 , ... Want to learn more about CRISPR-Cas ... that demonstrates how this advanced plant breeding technology is a more efficient way ... resources. It highlights the business’ principles, research and collaboration efforts in this area. ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab ... to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. ... City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WARSAW, Ind. , April 20, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Health Care Conference at the InterContinental Hotel in ... 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern ... can be accessed via Zimmer Biomet,s Investor Relations website ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: